Yang Quan-En, Fong Steven E, Li Kungui, Gonda Matthew A, Tobin Gregory J
Laboratory of Cell and Molecular Structure, SAIC/Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD 21702, USA.
Med Sci Monit. 2005 Jun;11(6):BR154-161. Epub 2005 May 25.
Although ex vivo expansion of bone marrow (BM) cells has been proposed as an effective method for the early recovery from pancytopenia in patients with bone marrow stem cell transplantation (BMT), the expansion potential and the long-term reconstitution capability of such BM cells is still controversial. We describe here a multiple cytokine medium (MCM) containing major hematopoietic stimulation factors and conditioned medium from PHA-stimulated murine spleen cells that permits the expansion of BM cells with long-term hematopoietic reconstitution capacity.
MATERIAL/METHODS: Male murine BM cells were expanded in MCM for 4 to 14 days and injected into lethally irradiated syngeneic female mice. The mice were maintained for 18 months after transplantation for evaluation of hematopoietic reconstitution.
The expanded cells contained pluripotent hematopoietic stem cells and lineage committed progenitors as well as terminally differentiated cells. They permitted full recovery of lethally irradiated mice in both early and late stages in same numbers equivalent to that of unexpanded cells. More than 80% of the progenitor cells were donor originated after 18 months. Expanded cells were able to be transduced with a retroviral vector expressing Beta-galactosidase, and continued to express the marker following BMT.
With the use of MCM, the quantity of donor cells from BM and other sources might be greatly reduced. Ex vivo expanded BM cells might also facilitate gene manipulation in vitro by retroviral vectors.
尽管骨髓(BM)细胞的体外扩增已被提出作为骨髓干细胞移植(BMT)患者全血细胞减少症早期恢复的有效方法,但此类BM细胞的扩增潜力和长期重建能力仍存在争议。我们在此描述一种含有主要造血刺激因子和PHA刺激的小鼠脾细胞条件培养基的多种细胞因子培养基(MCM),它能使具有长期造血重建能力的BM细胞得以扩增。
材料/方法:雄性小鼠BM细胞在MCM中扩增4至14天,然后注入经致死剂量照射的同基因雌性小鼠体内。移植后对小鼠维持观察18个月以评估造血重建情况。
扩增后的细胞包含多能造血干细胞、定向祖细胞以及终末分化细胞。它们能使经致死剂量照射的小鼠在早期和晚期都完全恢复,恢复程度与未扩增细胞相同。18个月后,超过80%的祖细胞来源于供体。扩增后的细胞能够被表达β-半乳糖苷酶的逆转录病毒载体转导,并且在骨髓移植后持续表达该标记物。
使用MCM可能会大大减少来自BM和其他来源的供体细胞数量。体外扩增的BM细胞也可能有助于通过逆转录病毒载体在体外进行基因操作。